Cmax= 2.5 μg/mL; Tmax= 4 h; AUC= 70.4 μg*h/mL; mean relative bioavailability of tablets=69% to 83%;
Vd= over 24 h dosing, enterohepatic circulation, multiple plasma concentration peaks;
(inhibitor of P-gp)